$AMLN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMYLIN PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMYLIN PHARMACEUTICALS INC. Get notifications about new insider transactions in AMYLIN PHARMACEUTICALS INC for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 18 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 40.50 | 1,000 | 40,500 | 15,963 | 17 K to 16 K (-5.90 %) |
| Nov 19 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 18.85 | 1,000 | 18,850 | 16,963 | 16 K to 17 K (+6.26 %) |
| Nov 19 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 5.73 | 5,000 | 28,650 | 12,404 | |
| Nov 19 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 41.68 | 5,000 | 208,392 | 120,037 | 125 K to 120 K (-4.00 %) |
| Nov 19 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 5.73 | 5,000 | 28,650 | 125,037 | 120 K to 125 K (+4.17 %) |
| Nov 15 2007 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Option Exercise | M | 2.66 | 70,000 | 185,920 | 64,400 | |
| Nov 15 2007 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Buy | M | 2.66 | 70,000 | 185,920 | 961,733 | 891.7 K to 961.7 K (+7.85 %) |
| Nov 13 2007 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 40.44 | 3,700 | 149,611 | 1,577,242 | 1.6 M to 1.6 M (-0.23 %) |
| Nov 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 41.49 | 10,000 | 414,927 | 891,733 | 901.7 K to 891.7 K (-1.11 %) |
| Nov 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Option Exercise | M | 16.54 | 2,000 | 33,080 | 30,749 | |
| Nov 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Sell | S | 44.16 | 2,000 | 88,311 | 23,844 | 25.8 K to 23.8 K (-7.74 %) |
| Nov 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Buy | M | 16.54 | 2,000 | 33,080 | 25,844 | 23.8 K to 25.8 K (+8.39 %) |
| Nov 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Option Exercise | M | 16.80 | 500 | 8,400 | 18,436 | |
| Nov 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Sell | S | 44.00 | 500 | 22,000 | 2,937 | 3.4 K to 2.9 K (-14.55 %) |
| Nov 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Buy | M | 16.80 | 500 | 8,400 | 3,437 | 2.9 K to 3.4 K (+17.02 %) |
| Nov 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 2.91 | 6,700 | 19,470 | 744 | |
| Nov 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 44.02 | 6,700 | 294,915 | 120,037 | 126.7 K to 120 K (-5.29 %) |
| Nov 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 2.91 | 6,700 | 19,470 | 126,737 | 120 K to 126.7 K (+5.58 %) |
| Oct 31 2007 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 46.46 | 3,700 | 171,913 | 1,580,942 | 1.6 M to 1.6 M (-0.23 %) |
| Nov 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 2,000 | 14,375 | 35,616 | |
| Nov 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 44.00 | 2,000 | 88,000 | 15,963 | 18 K to 16 K (-11.13 %) |
| Nov 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 2,000 | 14,375 | 17,963 | 16 K to 18 K (+12.53 %) |
| Oct 19 2007 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 46.00 | 10,000 | 459,961 | 901,733 | 911.7 K to 901.7 K (-1.10 %) |
| Oct 19 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 18.85 | 1,000 | 18,850 | 57,089 | |
| Oct 19 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 45.94 | 1,000 | 45,940 | 15,963 | 17 K to 16 K (-5.90 %) |
| Oct 19 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 18.85 | 1,000 | 18,850 | 16,963 | 16 K to 17 K (+6.26 %) |
| Oct 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 5.73 | 5,000 | 28,650 | 17,404 | |
| Oct 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 47.70 | 5,000 | 238,475 | 120,037 | 125 K to 120 K (-4.00 %) |
| Oct 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 5.73 | 5,000 | 28,650 | 125,037 | 120 K to 125 K (+4.17 %) |
| Oct 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 47.90 | 3,700 | 177,223 | 1,584,642 | 1.6 M to 1.6 M (-0.23 %) |
| Oct 09 2007 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | A | 0.00 | 375 | 0 | 5,463 | |
| Oct 09 2007 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Option Exercise | A | 0.00 | 388 | 0 | 6,722 | |
| Oct 09 2007 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Option Exercise | A | 0.00 | 287 | 0 | 5,556 | |
| Oct 09 2007 | AMLN | AMYLIN PHARMACEUTI ... | SKYLER JAY S | Director | Option Exercise | A | 0.00 | 287 | 0 | 4,883 | |
| Oct 09 2007 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Executive Advisor | Option Exercise | A | 0.00 | 287 | 0 | 628 | |
| Oct 09 2007 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | A | 0.00 | 300 | 0 | 1,412 | |
| Oct 09 2007 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | A | 0.00 | 425 | 0 | 3,149 | |
| Oct 09 2007 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | A | 0.00 | 325 | 0 | 1,140 | |
| Oct 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 50.17 | 10,000 | 501,663 | 911,733 | 921.7 K to 911.7 K (-1.08 %) |
| Oct 09 2007 | AMLN | AMYLIN PHARMACEUTI ... | ALTMAN STEVEN R | Director | Option Exercise | A | 0.00 | 300 | 0 | 1,423 | |
| Oct 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 1,000 | 7,188 | 37,616 | |
| Oct 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 50.00 | 1,000 | 50,000 | 15,847 | 16.8 K to 15.8 K (-5.94 %) |
| Oct 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 1,000 | 7,188 | 16,847 | 15.8 K to 16.8 K (+6.31 %) |
| Oct 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Option Exercise | M | 16.80 | 500 | 8,400 | 18,936 | |
| Oct 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Sell | S | 50.00 | 500 | 25,000 | 2,937 | 3.4 K to 2.9 K (-14.55 %) |
| Oct 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Buy | M | 16.80 | 500 | 8,400 | 3,437 | 2.9 K to 3.4 K (+17.02 %) |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Option Exercise | M | 16.54 | 2,000 | 33,080 | 32,749 | |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Sell | S | 49.67 | 2,000 | 99,341 | 23,485 | 25.5 K to 23.5 K (-7.85 %) |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Buy | M | 16.54 | 2,000 | 33,080 | 25,485 | 23.5 K to 25.5 K (+8.52 %) |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 11.13 | 3,400 | 37,825 | 10,350 | |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 9.63 | 3,300 | 31,763 | 7,900 | |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 49.77 | 3,400 | 169,210 | 119,530 | 122.9 K to 119.5 K (-2.77 %) |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 11.13 | 3,400 | 37,825 | 122,930 | 119.5 K to 122.9 K (+2.84 %) |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 49.77 | 3,300 | 164,233 | 119,530 | 122.8 K to 119.5 K (-2.69 %) |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 9.63 | 3,300 | 31,763 | 122,830 | 119.5 K to 122.8 K (+2.76 %) |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 49.54 | 3,700 | 183,286 | 1,588,342 | 1.6 M to 1.6 M (-0.23 %) |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Option Exercise | M | 16.80 | 500 | 8,400 | 19,436 | |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Sell | S | 49.83 | 500 | 24,915 | 2,937 | 3.4 K to 2.9 K (-14.55 %) |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Buy | M | 16.80 | 500 | 8,400 | 3,437 | 2.9 K to 3.4 K (+17.02 %) |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Option Exercise | M | 18.85 | 1,000 | 18,850 | 3,800 | |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Sell | S | 49.67 | 1,000 | 49,670 | 23,747 | 24.7 K to 23.7 K (-4.04 %) |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Buy | M | 18.85 | 1,000 | 18,850 | 24,747 | 23.7 K to 24.7 K (+4.21 %) |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 2,000 | 14,375 | 38,616 | |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 1,000 | 7,188 | 40,616 | |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 49.80 | 2,000 | 99,590 | 15,847 | 17.8 K to 15.8 K (-11.21 %) |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 2,000 | 14,375 | 17,847 | 15.8 K to 17.8 K (+12.62 %) |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 49.83 | 1,000 | 49,830 | 15,847 | 16.8 K to 15.8 K (-5.94 %) |
| Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 1,000 | 7,188 | 16,847 | 15.8 K to 16.8 K (+6.31 %) |
| Sep 28 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 13.25 | 3,000 | 39,750 | 638 | |
| Sep 28 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 49.98 | 3,000 | 149,932 | 23,242 | 26.2 K to 23.2 K (-11.43 %) |
| Sep 28 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 13.25 | 3,000 | 39,750 | 26,242 | 23.2 K to 26.2 K (+12.91 %) |
| Sep 27 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 5.73 | 5,000 | 28,650 | 22,404 | |
| Sep 27 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 50.00 | 5,000 | 250,000 | 119,530 | 124.5 K to 119.5 K (-4.02 %) |
| Sep 27 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 5.73 | 5,000 | 28,650 | 124,530 | 119.5 K to 124.5 K (+4.18 %) |
| Sep 19 2007 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 47.56 | 10,000 | 475,590 | 921,733 | 931.7 K to 921.7 K (-1.07 %) |
| Sep 19 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 1,000 | 7,188 | 41,616 | |
| Sep 19 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 47.75 | 1,000 | 47,750 | 15,847 | 16.8 K to 15.8 K (-5.94 %) |
| Sep 19 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 1,000 | 7,188 | 16,847 | 15.8 K to 16.8 K (+6.31 %) |
| Sep 18 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 5.73 | 5,000 | 28,650 | 27,404 | |
| Sep 18 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 48.74 | 5,000 | 243,711 | 119,530 | 124.5 K to 119.5 K (-4.02 %) |
| Sep 18 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 5.73 | 5,000 | 28,650 | 124,530 | 119.5 K to 124.5 K (+4.18 %) |
| Sep 18 2007 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 47.88 | 3,700 | 177,147 | 1,592,042 | 1.6 M to 1.6 M (-0.23 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Option Exercise | M | 22.60 | 113 | 2,554 | 4,482 | |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Option Exercise | M | 18.85 | 1,887 | 35,570 | 0 | |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Sell | S | 48.99 | 113 | 5,536 | 23,485 | 23.6 K to 23.5 K (-0.48 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Buy | M | 22.60 | 113 | 2,554 | 23,598 | 23.5 K to 23.6 K (+0.48 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Sell | S | 48.99 | 1,887 | 92,452 | 23,485 | 25.4 K to 23.5 K (-7.44 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Buy | M | 18.85 | 1,887 | 35,570 | 25,372 | 23.5 K to 25.4 K (+8.03 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 9.63 | 1,700 | 16,363 | 11,200 | |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 9.63 | 5,000 | 48,125 | 12,900 | |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 48.97 | 1,700 | 83,253 | 119,530 | 121.2 K to 119.5 K (-1.40 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 9.63 | 1,700 | 16,363 | 121,230 | 119.5 K to 121.2 K (+1.42 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 48.97 | 5,000 | 244,861 | 119,530 | 124.5 K to 119.5 K (-4.02 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 9.63 | 5,000 | 48,125 | 124,530 | 119.5 K to 124.5 K (+4.18 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 49.50 | 3,700 | 183,161 | 1,595,742 | 1.6 M to 1.6 M (-0.23 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Executive Advisor | Option Exercise | M | 23.00 | 1,449 | 33,327 | 0 | |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Executive Advisor | Option Exercise | M | 16.54 | 1 | 17 | 6,162 | |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Executive Advisor | Buy | M | 16.54 | 1 | 17 | 148,973 | 149 K to 149 K (0.00 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Executive Advisor | Buy | M | 23.00 | 1,449 | 33,327 | 148,972 | 147.5 K to 149 K (+0.98 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Option Exercise | M | 16.80 | 500 | 8,400 | 19,936 | |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Option Exercise | M | 16.80 | 500 | 8,400 | 20,436 | |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Sell | S | 50.00 | 500 | 25,000 | 2,937 | 3.4 K to 2.9 K (-14.55 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Buy | M | 16.80 | 500 | 8,400 | 3,437 | 2.9 K to 3.4 K (+17.02 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Sell | S | 49.00 | 500 | 24,500 | 2,937 | 3.4 K to 2.9 K (-14.55 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Buy | M | 16.80 | 500 | 8,400 | 3,437 | 2.9 K to 3.4 K (+17.02 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Option Exercise | M | 18.85 | 1,000 | 18,850 | 4,800 | |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Sell | S | 48.99 | 1,000 | 48,994 | 23,747 | 24.7 K to 23.7 K (-4.04 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Buy | M | 18.85 | 1,000 | 18,850 | 24,747 | 23.7 K to 24.7 K (+4.21 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 49.49 | 10,000 | 494,918 | 931,733 | 941.7 K to 931.7 K (-1.06 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 1,000 | 7,188 | 42,616 | |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 3,000 | 21,563 | 43,616 | |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 50.00 | 1,000 | 50,000 | 15,847 | 16.8 K to 15.8 K (-5.94 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 1,000 | 7,188 | 16,847 | 15.8 K to 16.8 K (+6.31 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 49.00 | 3,000 | 147,000 | 15,847 | 18.8 K to 15.8 K (-15.92 %) |
| Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 3,000 | 21,563 | 18,847 | 15.8 K to 18.8 K (+18.93 %) |
| Aug 31 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 13.25 | 3,000 | 39,750 | 3,638 | |
| Aug 31 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 48.86 | 3,000 | 146,575 | 23,242 | 26.2 K to 23.2 K (-11.43 %) |
| Aug 31 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 13.25 | 3,000 | 39,750 | 26,242 | 23.2 K to 26.2 K (+12.91 %) |
| Aug 21 2007 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 48.92 | 3,700 | 180,995 | 1,599,442 | 1.6 M to 1.6 M (-0.23 %) |
| Aug 21 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 11.13 | 1,000 | 11,125 | 6,313 | |
| Aug 21 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 49.00 | 1,000 | 49,000 | 15,847 | 16.8 K to 15.8 K (-5.94 %) |
| Aug 21 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 11.13 | 1,000 | 11,125 | 16,847 | 15.8 K to 16.8 K (+6.31 %) |
| Aug 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 47.65 | 100 | 4,765 | 941,733 | 941.8 K to 941.7 K (-0.01 %) |
| Aug 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 48.26 | 9,900 | 477,806 | 941,833 | 951.7 K to 941.8 K (-1.04 %) |
| Aug 16 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 14.28 | 5,000 | 71,405 | 5,436 | |
| Aug 16 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 14.28 | 5,000 | 71,405 | 10,436 | |
| Aug 16 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 50.00 | 5,000 | 250,000 | 119,530 | 124.5 K to 119.5 K (-4.02 %) |
| Aug 16 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 14.28 | 5,000 | 71,405 | 124,530 | 119.5 K to 124.5 K (+4.18 %) |
| Aug 16 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 48.20 | 5,000 | 241,003 | 119,530 | 124.5 K to 119.5 K (-4.02 %) |
| Aug 16 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 14.28 | 5,000 | 71,405 | 124,530 | 119.5 K to 124.5 K (+4.18 %) |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Sell | S | 51.44 | 3,334 | 171,516 | 22,000 | 25.3 K to 22 K (-13.16 %) |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Sell | S | 50.18 | 3,334 | 167,287 | 25,334 | 28.7 K to 25.3 K (-11.63 %) |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Sell | S | 50.03 | 2,000 | 100,069 | 3,500 | 5.5 K to 3.5 K (-36.36 %) |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 14.28 | 5,000 | 71,405 | 15,436 | |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 50.00 | 5,000 | 250,000 | 119,530 | 124.5 K to 119.5 K (-4.02 %) |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 14.28 | 5,000 | 71,405 | 124,530 | 119.5 K to 124.5 K (+4.18 %) |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Executive Advisor | Option Exercise | M | 19.24 | 12,000 | 230,880 | 0 | |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Executive Advisor | Option Exercise | M | 11.03 | 3,000 | 33,090 | 0 | |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Executive Advisor | Option Exercise | M | 9.16 | 8,000 | 73,280 | 0 | |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Executive Advisor | Sell | S | 51.11 | 8,000 | 408,858 | 147,523 | 155.5 K to 147.5 K (-5.14 %) |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Executive Advisor | Buy | M | 9.16 | 8,000 | 73,280 | 155,523 | 147.5 K to 155.5 K (+5.42 %) |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Executive Advisor | Sell | S | 51.11 | 3,000 | 153,322 | 147,523 | 150.5 K to 147.5 K (-1.99 %) |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Executive Advisor | Buy | M | 11.03 | 3,000 | 33,090 | 150,523 | 147.5 K to 150.5 K (+2.03 %) |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Executive Advisor | Sell | S | 51.78 | 12,000 | 621,418 | 147,523 | 159.5 K to 147.5 K (-7.52 %) |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Executive Advisor | Buy | M | 19.24 | 12,000 | 230,880 | 159,523 | 147.5 K to 159.5 K (+8.13 %) |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Option Exercise | M | 16.80 | 500 | 8,400 | 20,936 | |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Sell | S | 50.00 | 500 | 25,000 | 2,937 | 3.4 K to 2.9 K (-14.55 %) |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Buy | M | 16.80 | 500 | 8,400 | 3,437 | 2.9 K to 3.4 K (+17.02 %) |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 1,000 | 7,188 | 46,616 | |
| Aug 08 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 1,000 | 7,188 | 47,616 |